|
注册号: Registration number: |
ChiCTR2300067421 |
|
最近更新日期: Date of Last Refreshed on: |
2023-06-23 19:52:59 |
|
注册时间: Date of Registration: |
2023-01-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
社会生态学视角下老年住院患者安全照护理论的构建及验证 |
|
Public title: |
Construction and validation of safe care theory for elderly inpatients from the perspective of socio-ecological model |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
社会生态学视角下老年住院患者安全照护理论的构建及验证 |
|
Scientific title: |
Construction and validation of safe care theory for elderly inpatients from the perspective of socio-ecological model |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
严露培 |
研究负责人: |
胡秀英 |
|
Applicant: |
Yan Lupei |
Study leader: |
Hu Xiuying |
|
申请注册联系人电话: Applicant telephone: |
+86 137 0903 9560 |
研究负责人电话:
Study leader's |
+86 189 8060 1178 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
charmingpei24@163.com |
研究负责人电子邮件: Study leader's E-mail: |
huxiuying@scu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
成都市武侯区国学巷37号 |
研究负责人通讯地址: |
成都市武侯区国学巷37号 |
|
Applicant address: |
37 Guo Xue Street, WUhou District, Chengdu, Sichuan |
Study leader's address: |
37 Guo Xue Street, WUhou District, Chengdu, Sichuan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
四川大学华西医院 |
||
|
Applicant's institution: |
West China Hospital, Sichuan University |
||
|
研究负责人所在单位: |
四川大学华西医院 |
||
|
Affiliation of the Leader: |
West China Hospital, Sichuan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022年审(1598)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川大学华西医院生物医学伦理审查委员会 |
||
|
Name of the ethic committee: |
the Ethics Committee of West China School of Medicine/West China Hospital, Sichuan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-10-25 00:00:00 | ||
|
伦理委员会联系人: |
彭淑贤 |
||
|
Contact Name of the ethic committee: |
Peng Shuxian |
||
|
伦理委员会联系地址: |
成都市武侯区国学巷37号 |
||
|
Contact Address of the ethic committee: |
37 Guo Xue Street, WUhou District, Chengdu, Sichuan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 85423237 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
四川大学华西医院 |
||||||||||||||||||||||
|
Primary sponsor: |
West China Hospital, Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
成都市武侯区国学巷37号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
37 Guo Xue Street, WUhou District, Chengdu, Sichuan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
四川省科技厅项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
the Sichuan Science and Technology Program |
||||||||||||||||||||||
|
研究疾病: |
老年住院患者 |
||||||||||||||||||||||
|
Target disease: |
Elderly |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
1.总结老年住院患者的健康威胁及院内照护的安全威胁,从社会生态学及约克郡影响因素框架的角度,分析老年住院患者安全照护的影响机制,构建安全照护概念模型。 2.了解老年住院患者的照护现状及存在问题,识别院内安全照护体系的核心概念及潜在联系,为老年住院患者安全照护理论模型的构建提供现实依据。 3.检验安全照护理论模型的内容要素,完善老年患者安全照护理论,为促进老年住院患者安全照护的发展及实践提供理论支撑,助力院内安全照护体系的提质增效。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to examine which and how factors impact safe care for elderly inpatients at different levels and outline a safe care theory to provide valuable information on developing and practicing the safe care system in the hospital. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
老年患者排除标准: 1.病情易发生变化的危急重症和(或)疾病终末期患者; 2.罹患精神疾病,认知障碍者。 照护者排除标准: 1.近三个月内遭遇过重大变故者。 护士排除标准: 1.见习护生; 2.实习护士。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria for elderly patients: 1. Critical and/or end-stage patients with easily changing conditions; 2. Individuals with mental illness or cognitive impairment. Exclusion criteria for caregivers: 1. Those who have experienced significant changes within the past three months. Nurse exclusion criteria: 1. Intern nursing students; 2. Intern nurses. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-02-01 00:00:00至 To 2025-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-02-01 00:00:00 至 To 2025-12-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
方便抽样 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
convenience sample |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
No database sharing |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
问卷收集 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
questionnaires investigation |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |